For Exclusive Distribution to GB Trade and Medical Media REZZAYO® (rezafungin) is approved for treating invasive candidiasis in adults. Adherence to official guidelines regarding the appropriate use of antifungal agents is recommended.2 The marketing authorization stems from favorable outcomes in…
Takeda’s Chief Financial Officer Costa Saroukos Announces Departure; Milano Furuta to Assume Role Effective April 1, 2024 TOKYO, Japan — In an announcement today, Takeda disclosed that Costa Saroukos, the current Chief Financial Officer, has made the decision to resign…
Atara Biotherapeutics and Pierre Fabre Laboratories Publish Data from Phase 3 ALLELE Tab-cel® Trial in The Lancet Oncology” Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, and Pierre Fabre Laboratories, a global player in oncology responsible for the…
Solidsoft Reply, a subsidiary of the Reply Group specializing in crafting business solutions on the Microsoft Azure cloud, has successfully migrated Finland’s National Medicines Verification System to its National Blueprint solution. Designed to comply with the EU Falsified Medicines Directive…
Kindeva Drug Delivery (Kindeva), a prominent player in drug and medical device combination products globally, has unveiled the expansion of its analytical services, establishing a new global business unit. This unit is dedicated to providing integrated and standalone analytical support…
Pioneering health tech platform Ally Health and leading global healthcare delivery partner Acacium Group have joined forces in a new partnership aimed at revolutionizing the delivery of community care. With over 70% of medical decisions requiring follow-up appointments, Ally Health’s…
Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company specializing in the design, manufacturing, and sale of the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, proudly announces…
-GC Aesthetics® (GCA), a privately held medical technology company providing aesthetic and reconstructive solutions to the global healthcare market, We announced that our implant, PERLE™, was recently featured in an independently peer-reviewed paper published in the Aesthetic Surgery Journal Open…
ObjectiveHealth, a leading integrated specialty research network and technology company, announced today that it has secured a strategic growth investment from Vitruvian Partners, a leading global growth-focused investment firm. ObjectiveHealth is an innovator in clinical research, seamlessly integrating clinical trials…
a digital health technology company that delivers precision measurement of mental health through AI, today announced its inclusion in the U.S. Food and Drug Administration (FDA) Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program. Under the program,…
Oversubscribed Seed round led by Meridian Street Capital and B Capital Isaac Health, a digital health company emerging as a national leader for brain health, announced today the successful completion of its oversubscribed $5.7 million Seed round. The round was…
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2023 fourth quarter and year end results for the period ended September 30, 2023. “I am pleased to announce that…